EU Customer Economic Perception Study

Customer Perceptions of Quality of Services

of Hospitals across Europe

Study TypeTarget Group

Target Group 1: CXO’s (CEO, CMO, CFO) – Target Group 2: Supply chain managers (Hospital VP or Director of Supply Chain) Target Group 3: Head of departments (administrative physicians)• Electro physiologists (Cardiac Electro

physiologists)• Vascular surgeons• Interventional Cardiologists • Gastroenterologists • Gynecologists • Urologists

UK, France,Spain,

Germany, Italy

Geography

N Size

30 across all regions and all specialties

What was the research problem?The development and growth of the service industry are huge. Numerous studies show that the establishment of high quality of services is directly related to profits, market share, and cost savings.During treatment, patients hope and trust that their health-related problems will be appropriately addressed. However, it is estimated that in the EU Member States, between 8% to 12% of patients admitted to hospitals suffer from adverse events while receiving healthcare. In addition, the European Centre for Disease Prevention and Control (ECDC) estimates that healthcare-associated toxicities occur in 5% of hospitalized patients. This would equate to 4.1 million patients a year in the EU indicating around 37,000 estimated deaths to occur every year due to such infections.

Since the safety of a patient is a serious concern, new health technologies [e.g. new pharmaceuticals or new devices] in many countries are being meticulously assessed by national or regional health authorities before decisions on investment and implementation are made at the local hospitals. Healthcare reform urges hospitals to look more critically at what they purchase; device makers must prove their products’ worth.The overall aim of this study is to understand what information is required by the European hospital managers while making investment decisions on investment in new health technologies. However, little is known about stakeholders' perceptions and assessment of innovative devices. Herein, our client wanted us to help investigate the perceptions regarding innovative medical devices of their chief users (physicians and surgeons) as well as those of hospital pharmacists because they are responsible for the purchase and management of sterile medical devices.

What were the challenges?

A hard-to-reach healthcare decision makers across different segments of the industry was a challenge.

How did Borderless Access solve the problem?

A systematic literature review was carried out before starting this study.A blind quant survey in-depth interviews were conducted across 200+ hospitals from each geography to determine who the decision makers/influencers are across healthcare product areas.

Outcome

Our team was able to wrap this study in all markets and was successful in achieving the required survey results, considering the tight timeline, we requested the client to allow us more time in the field to achieve as these are healthcare professionals and a tough target audience. Client extended the field time and we were able to achieve these results. Although the client was well aware of the tough to reach audience segment in healthcare, with our renowned capability in penetrating a tough-to-reach audience segment. The client went on to show confidence in our capability in execution and really appreciated the amount of dedication & commitment our team showed in flawlessly delivering the results.

6

Contact-Us

UKLONDONTel :  +44 771 840 3458

CALIFORNIATel : +1 818 358 4633

USA

DUBAITel :  +97 150 137 3145

MunichTel :  +49 (0) 176 650 94033

UAE

GERMANY

BANGALORETel : +91 804 931 3800

India

Connect with us

www.borderlessaccess.com

Business Enquiriesmarketing@borderlessaccess.com